Three Drugs Purported To Be Manufactured By ‘Meg Lifesciences’ Are Spurious: DCA Telangana

Hyderabad: V.B. Kamalasan Reddy (IPS), Director General, Telangana DCA said in press release that “It has come to the attention of the Drugs Control Administration, Telangana, that certain drugs claimed on the label as manufactured by ‘Meg Lifesciences, Khasara No. 47/5, Palli Gaon, Distt. Sirmour, 173 001,’ are being circulated in the market. Upon investigation, it has been confirmed that ‘Meg Lifesciences’ is a fictitious/non-existent company. These drugs have been found to be falsified medicines, manufactured by anti-social elements, containing no active ingredient (‘Nil’ medicine). They have been found to contain chalk powder and starch, posing significant health risks to consumers.

In light of these grave findings, the Drugs Control Administration, Telangana, hereby issues a Spurious Drug Alert and Stop Use Notice for all drugs claiming to be manufactured by ‘Meg Lifesciences.’

Consumers and healthcare professionals are informed to ‘STOP USE’ immediately – to discontinue the use of any drugs claiming to be manufactured by ‘Meg Lifesciences.’

Retailers and wholesalers are directed to ‘STOP’ the sale and distribution of any drugs bearing the label of ‘Meg Lifesciences,’ and to inform the area Drugs Inspector immediately.”

The Drugs Control Administration, Telangana, is taking stringent measures to curb the menace of spurious drugs and has seized stocks claimed to be manufactured by Meg Lifesciences worth Rs. 33.35 lakhs during the recent raids carried out by DCA. Cases have been registered against several offenders involved in this spurious drugs racket.

DCA is actively working to ensure the removal of these spurious drugs from the market.

Drugs Control Administration urges the public to remain vigilant and report any information regarding the distribution or sale of drugs from this purported manufacturer ‘Meg Lifesciences’:

  • To the nearest Drugs Control Administration Office – You may report to the local Drugs Inspector or Assistant Director, Drug Control Administration. The details of the contact number and address of the office are available on the Drugs Control Administration, Telangana website https://dca.telangana.gov.in/ under the ‘Key Contacts’ section (or)
  • To the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.” said the press release.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre